| ²é¿´: 233 | »Ø¸´: 3 | |||
| µ±Ç°Ö÷ÌâÒѾ´æµµ¡£ | |||
¾²6873ľ³æ (³õÈëÎÄ̳)
|
[½»Á÷]
ÇóÖú£ºÖÐÒëÓ¢~
|
||
|
ÉúÎïÀûÓöÈÊÇÆÀ¼ÛÖÆ¼ÁÖÊÁ¿ºÍÈ·¶¨¸øÒ©Í¾¾¶µÄÖØÒª²ÎÊýÖ®Ò»¡£ÉúÎïÀûÓöȵÄÔ¤²âÓкܶàÖÖ·½·¨£¬ÀýÈç·ÅÉäÐÔ±ê¼Ç·¨£¬ºÐÊÒ¸øÒ©·¨µÈ¡£ºÐʽ¸øÒ©·¨Êǽ«¶àÖÖÒ©Îïͬʱ¸øÓèÿֻ¶¯Î°´³£¹æÈ¡Ñùʱ¼ä£¬ÔËÓÃHPLC/MSÁªÓü¼Êõ½øÐÐÑùÆ·´¦Àí·ÖÎö£¬ÊÇÒ»ÖÖ¸ßͨÁ¿Ò©ÎïɸѡµÄ·½·¨¡£Ä¿Ç°ºÐʽ¸øÒ©·¨µÄÓ¦Óò¢²»¹ã·º£¬Òò´Ë¾ßÓйãÀ«µÄÑо¿¿Õ¼ä¡£±¾ÎľͺÐʽ¸øÒ©·¨Ô¤²âÈ˿ڷþÉúÎïÀûÓöȵÄÏÖ×´ºÍ½øÕ¹×÷Ò»¼òÒª¸ÅÊö¡£ [ Last edited by ¾²6873 on 2009-2-12 at 22:28 ] |
» ²ÂÄãϲ»¶
Ò»Ö¾Ô¸ÖÐÄÏ´óѧÀíѧ»¯Ñ§
ÒѾÓÐ3È˻ظ´
²ÄÁÏ284Çóµ÷¼Á£¬Ò»Ö¾Ô¸Ö£ÖÝ´óѧӢһÊý¶þר˶
ÒѾÓÐ9È˻ظ´
²ÄÁÏ»¯¹¤µ÷¼Á
ÒѾÓÐ9È˻ظ´
»¯¹¤299·ÖÇóµ÷¼Á Ò»Ö¾Ô¸985Âä°ñ
ÒѾÓÐ4È˻ظ´
290Çóµ÷¼Á
ÒѾÓÐ9È˻ظ´
0856»¯¹¤×¨Ë¶Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
0856²ÄÁÏרҵ298·ÖÓпÆÑоÀú ˶ʿÑо¿Éúµ÷¼Á×Ô¼öÐÅ
ÒѾÓÐ6È˻ظ´
306·Ö²ÄÁϵ÷¼Á
ÒѾÓÐ4È˻ظ´
302²ÄÁϹ¤³ÌÇóµ÷¼Á
ÒѾÓÐ5È˻ظ´
272Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
¶«´óÍõ
Ìú¸Ëľ³æ (ÕýʽдÊÖ)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 8206.7
- É¢½ð: 21
- ºì»¨: 1
- Ìû×Ó: 389
- ÔÚÏß: 49.6Сʱ
- ³æºÅ: 425922
- ×¢²á: 2007-07-28
- ÐÔ±ð: GG
- רҵ: ½ðÊô²ÄÁϵÄÖÆ±¸¿ÆÑ§Óë¿çѧ
2Â¥2009-02-12 22:43:10
¾²6873
ľ³æ (³õÈëÎÄ̳)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 1498
- É¢½ð: 3
- Ìû×Ó: 50
- ÔÚÏß: 30.4Сʱ
- ³æºÅ: 659914
- ×¢²á: 2008-11-22
- ÐÔ±ð: MM
- רҵ: Ò©¼Áѧ
3Â¥2009-02-12 23:42:50
wshbinzhang
Ìú¸Ëľ³æ (ÖªÃû×÷¼Ò)
- ·ÒëEPI: 3
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 7807.3
- É¢½ð: 200
- Ìû×Ó: 5830
- ÔÚÏß: 153.7Сʱ
- ³æºÅ: 478725
- ×¢²á: 2007-12-14
- רҵ: ½á¹¹ÌÕ´É
¡ï ¡ï ¡ï ¡ï
¾²6873(½ð±Ò+4,VIP+0):лл²ÎÓë~ 2-14 09:55
¾²6873(½ð±Ò+4,VIP+0):лл²ÎÓë~ 2-14 09:55
|
Bioavailability is one of the most important parameters to evaluate pharmaceutical preparation quality and determine administration approach. Bioavailability can be predicted using various methods. Up to now, xx has not been widely employed; therefore, intensive research is necessary. This paper summarizes the current situations and developments about oral administration of bioavailability for human. |
4Â¥2009-02-13 15:42:24













»Ø¸´´ËÂ¥
10